(Q44383460)

2 December 2017

title

Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease (English)

1 reference

2 December 2017

1 reference

2

1 reference

2 December 2017

11

1 reference

2 December 2017

Christian Kubisch

1

1 reference

2 December 2017

Monika von Düring

3

1 reference

2 December 2017

Regina C Betz

4

1 reference

2 December 2017

Hans-Hilmar Goebel

5

1 reference

2 December 2017

Susanne Zahn

6

1 reference

2 December 2017

Antje Ehrbrecht

7

1 reference

2 December 2017

Jan Aasly

8

1 reference

2 December 2017

Anja Schroers

9

1 reference

2 December 2017

Nikola Popovic

10

1 reference

2 December 2017

J Michael Schröder

12

1 reference

2 December 2017

Thomas Brüning

13

1 reference

2 December 2017

Jean-Pierre Malin

14

1 reference

2 December 2017

Britta Fricke

15

1 reference

2 December 2017

Hans-Michael Meinck

16

1 reference

2 December 2017

Torberg Torbergsen

17

1 reference

2 December 2017

Hartmut Engels

18

1 reference

2 December 2017

Bruno Voss

19

1 reference

2 December 2017

Matthias Vorgerd

20

1 reference

2 December 2017

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

53

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

512-520

1 reference

Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease

2 December 2017

cites work

1 reference

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy

21 January 2018

1 reference

Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy

21 January 2018

1 reference

Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy

21 January 2018

1 reference

Mutation in the CAV3 gene causes partial caveolin-3 deficiency and persistent elevated levels of serum creatine kinase

21 January 2018

1 reference

Caveolin-3 in muscular dystrophy

21 January 2018

1 reference

Mutations in the caveolin-3 gene: When are they pathogenic?

21 January 2018

1 reference

Severe autosomal recessive rippling muscle disease

21 January 2018

1 reference

Membrane microdomains and caveolae

21 January 2018

1 reference

Caveolin-deficient mice: insights into caveolar function human disease

21 January 2018

1 reference

Caveolae and caveolin-3 in muscular dystrophy

21 January 2018

1 reference

Nitric oxide synthases: which, where, how, and why?

21 January 2018

1 reference

Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity

21 January 2018

1 reference

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

21 January 2018

1 reference

A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita thomsen

21 January 2018

1 reference

New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling

21 January 2018

1 reference

Nitric oxide synthase is concentrated at the skeletal muscle endplate.

21 January 2018

1 reference

Caveolin-3 deficiency causes muscle degeneration in mice

21 January 2018

1 reference

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities

21 January 2018

1 reference

Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency

21 January 2018

1 reference

The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle

21 January 2018

1 reference

The earliest pathologic alterations in dysferlinopathy

21 January 2018

1 reference

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10501

1 reference

2 December 2017

1 reference